Anti-interleukin-4 monoclonal antibody 11B11

Drug Profile

Anti-interleukin-4 monoclonal antibody 11B11

Alternative Names: 11B11; Anti-interleukin-4 antibody 11B11

Latest Information Update: 19 Nov 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial sources; University of Tokyo
  • Class Monoclonal antibodies
  • Mechanism of Action Interleukin 4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Graft-versus-host disease; Systemic lupus erythematosus

Most Recent Events

  • 19 Nov 2003 Discontinued - Preclinical for Cancer in Japan (Intraperitoneal)
  • 19 Nov 2003 Discontinued - Preclinical for Graft-versus-host disease in Germany (unspecified route)
  • 19 Nov 2003 Discontinued - Preclinical for Graft-versus-host disease in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top